Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Provincial Landscape
Snapshot: 2026-10-21
Gansu Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 5 active clinical trials for multiple myeloma hosted across 2 tertiary medical centers in Gansu (including The First Hospital of Lanzhou University, Gansu Provincial Hospital).
Active Trials
5
Hospitals
2
Therapies
Bispecific & Multispecific Antibodies / Monoclonal Antibodies
Participating Medical Centers (2)
The First Hospital of Lanzhou UniversityGansu Provincial Hospital
Active Studies in Gansu (5)
Population synthesized by CMDNShowing 0 published English records of 5 registry trials.
All 5 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.